Release
📈 Stocks
Lakewood-Amedex Shares Rise on Positive Nu-3 Preclinical Data
(3 days ago)
Lakewood-Amedex (LABT) advances its clinical pipeline after presenting data showing Nu-3's broad-spectrum efficacy and low resistance potential in treating diabetic foot ulcers.